Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
December 25, 2018
A randomized, single ascending dose study of intravenous BIIB092 in healthy participants
Irfan A Qureshi, Giridhar Tirucherai, Michael K Ahlijanian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Michael Grundman, Susan Catalano, Mary E Hamby, et al.
Archives of Neurology
|
February 13, 2003
Estrogen levels do not correlate with improvement in cognition
Leon J Thal, Ronald G Thomas, Ruth Mulnard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Alireza Faridar, Nazaret Gamez, Michael Grundman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 5, 2012
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials
Jesse M Cedarbaum, Mark Jaros, Chito Hernandez, et al.
Annals of Neurology
|
July 2, 2003
Laboratory investigations and treatment in frontotemporal dementia
Florence Pasquier, Toshiya Fukui, Marie Sarazin, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N Lizama, Jennifer Kahle, Susan M Catalano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 7, 2012
The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials
Nandini Raghavan, Mahesh N Samtani, Michael Farnum, et al.
Archives of Neurology
|
April 5, 2012
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease
Kaj Blennow, Henrik Zetterberg, Juha O Rinne, et al.
Alzheimer Disease and Associated Disorders
|
May 28, 2010
A single ascending dose study of bapineuzumab in patients with Alzheimer disease
Ronald S Black, Reisa A Sperling, Beth Safirstein, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Alzheimer'S & Dementia (New York, N. Y.)
|
December 25, 2018
A randomized, single ascending dose study of intravenous BIIB092 in healthy participants
Irfan A Qureshi, Giridhar Tirucherai, Michael K Ahlijanian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Michael Grundman, Susan Catalano, Mary E Hamby, et al.
Archives of Neurology
|
February 13, 2003
Estrogen levels do not correlate with improvement in cognition
Leon J Thal, Ronald G Thomas, Ruth Mulnard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Alireza Faridar, Nazaret Gamez, Michael Grundman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 5, 2012
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials
Jesse M Cedarbaum, Mark Jaros, Chito Hernandez, et al.
Annals of Neurology
|
July 2, 2003
Laboratory investigations and treatment in frontotemporal dementia
Florence Pasquier, Toshiya Fukui, Marie Sarazin, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N Lizama, Jennifer Kahle, Susan M Catalano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 7, 2012
The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials
Nandini Raghavan, Mahesh N Samtani, Michael Farnum, et al.
Archives of Neurology
|
April 5, 2012
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease
Kaj Blennow, Henrik Zetterberg, Juha O Rinne, et al.
Alzheimer Disease and Associated Disorders
|
May 28, 2010
A single ascending dose study of bapineuzumab in patients with Alzheimer disease
Ronald S Black, Reisa A Sperling, Beth Safirstein, et al.
Page
of 8